1Harris NL, Jaffe ES, Diebold J, et al. The World Health Organization classification of hematological malignancies report of the Clinical Advisory Committee Meeting, Airlie House Virginia,November 1997. Mod Pathol, 2000,13 : 193-207.
2Naeim F, ed. Pathology of bone marrow. Baltimore: Williams & Wilkins, 1997. 140-160.
3Heaney ML, Golde DW. Myelodysplasia. N Engl J Meal,1999,340:1649-1660.
4Naeim F. Atlas of bone marrow and blood pathology. Saunders:Wiliams & Wilkins, 2001.31-45.
9[2]Vardiman JW, Harris NL, Brunning RD. The World Health Organization(WHO) classification of the myeloid neoplasms[J]. Blood, 2002,100(7):2292-2302.
10[5]Houwerzijl E J, Blom NR, van der Want J J, et al.Increased peripheral platelet destruction and caspase-3-independent programmed cell death of bone marrow megakaryocytes in myelodysplastic patients [J]. Blood,2005,105(9):3472-3479.
